Drug to Treat Schizophrenia (Phase 2 study)

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Drug to Treat Schizophrenia (Phase 2 study), covering 2011-05-19 to 2011-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of Drug to Treat Schizophrenia [Phase 2]